sheder1 wrote:
> http://www.boston.com/bostonglobe/id...o_not_give_up/ avastin temodar Tarceva
Her brother's combo is in Phase II clinical trial
http://clinicaltrials.gov/ct2/show/NCT00535249
Study Start Date: September 2007
Estimated Primary Completion Date: September 2009 (Final data collection date for
primary outcome measure)
Detailed Description:
OBJECTIVES:
Primary
* To determine the overall and progression-free survival of patients with newly
diagnosed glioblastoma multiforme or gliosarcoma treated with adjuvant bevacizumab,
temozolomide, and erlotinib hydrochloride after radiotherapy and temozolomide.
Secondary
* To collect safety data on this regimen in these patients.